Mycobacterium avium subsp. paratuberculosis (Johne's Disease) in Cattle: Etiology, Diagnostics, and Control
Etiology and Taxonomy
Mycobacterium avium subsp. paratuberculosis (MAP) is the etiologic agent of Johne's disease in cattle. MAP is a slow-growing, acid-fast, gram-positive bacillus within the Mycobacterium avium complex. It is an obligate intracellular pathogen that exhibits a tropism for macrophages within the intestinal lamina propria. A defining phenotypic characteristic of MAP is its mycobactin dependence for in vitro cultivation, a feature that distinguishes it from other M. avium subspecies. The organism possesses a thick, lipid-rich cell wall composed of mycolic acids, peptidoglycan, and arabinogalactan, conferring resistance to environmental degradation and enabling survival for extended periods in feces, water, and soil.
Molecular characterization of MAP has identified two major strain types: Type S (sheep-type, also referred to as Type I) and Type C (cattle-type, also referred to as Type II). Type C strains are most commonly associated with bovine paratuberculosis globally. Genotypic discrimination is achieved through analysis of insertion sequences, primarily IS900 and IS1311, the latter of which permits typing via restriction fragment length polymorphism (RFLP) or polymerase chain reaction (PCR) based methods. IS900 remains the gold-standard genetic target for diagnostic PCR assays due to its high copy number and specificity for MAP.
Epidemiology
MAP infects a wide range of domestic and wild ruminants, with cattle representing the primary reservoir for bovine disease. Transmission occurs predominantly via the fecal-oral route. Calves under six months of age are the most susceptible to infection, as they exhibit the highest density of Peyer's patches in the ileum, which serve as the primary portal of entry. Adult cattle are less susceptible to experimental infection but may still acquire the pathogen under conditions of high environmental contamination.
The protracted incubation period of Johne's disease, typically spanning two to five years, complicates epidemiological tracking. Most infected animals are subclinical shedders that intermittently excrete MAP in feces. This subclinical shedding maintains the contamination cycle within herds. Environmental persistence of MAP is a critical epidemiological factor; the organism can survive in shaded, moist environments for up to one year, making pasture and water troughs long-term reservoirs of infection.
Clinical Signs
Johne's disease in cattle is characterized by a progressive, afebrile, chronic enteritis. Clinical disease typically manifests in adult animals between two and six years of age. The earliest clinical sign is a decline in milk production, often accompanied by poor body condition despite a normal appetite.
The hallmark clinical sign is chronic, profuse, non-responsive diarrhea. The feces are often described as watery or pasty without blood or mucus, reflecting the underlying granulomatous inflammation of the small intestine. As the disease progresses, protein-losing enteropathy leads to subcutaneous edema, particularly in the submandibular region (intermandibular edema). Severe cachexia results from malabsorption and maldigestion. Terminal stages are marked by emaciation, dehydration, and hypoproteinemia. Affected animals remain afebrile throughout the course of the disease unless secondary bacterial infections supervene.
Pathology
Gross pathology presents a thickened, corrugated intestinal mucosa, particularly in the ileum, ileocecal valve, and jejunum. The serosal lymphatic vessels may appear dilated and beaded. Mesenteric lymph nodes are often enlarged and edematous.
Histopathological examination reveals diffuse granulomatous enteritis. The lamina propria is massively infiltrated by macrophages, epithelioid cells, and multinucleated giant cells. These macrophages are filled with clumps of acid-fast bacilli, demonstrable with Ziehl-Neelsen staining. In advanced cases, granulomas may also be identified in regional lymph nodes and, rarely, in the liver.
Diagnosis
Diagnosis of MAP infection is a multi-tiered process that depends on the stage of infection. No single test achieves perfect sensitivity across all disease stages. The latency of infection and intermittent shedding necessitate a combination of serological, molecular, and culture-based methods for herd-level diagnosis.
Fecal Culture
Fecal culture has historically been the reference standard for antemortem diagnosis. However, MAP is an extremely slow-growing organism. Solid media (Herrold's egg yolk medium with mycobactin J) requires 12 to 16 weeks for visible colony formation. Liquid culture systems (radiometric or fluorometric) reduce detection time to 4 to 8 weeks. Culture is highly specific but suffers from low sensitivity in subclinical shedders and requires significant laboratory infrastructure.
Polymerase Chain Reaction (PCR)
Direct fecal PCR targeting IS900 has largely replaced culture for routine diagnosis in many diagnostic laboratories. PCR provides a same-day to 48-hour turnaround time and offers sensitivity comparable to liquid culture for high- and moderate-level shedders. Quantitative real-time PCR (qPCR) allows estimation of fecal bacterial load, which correlates with disease stage and transmission risk. Pooled fecal PCR (testing groups of five animals) is a cost-effective screening strategy for herd-level surveillance. An overview of diagnostic pathways is presented in the decision diagram below.
graph TD
A[Adult cattle with chronic diarrhea or wasting], > B{Clinical suspicion}
B, > C[Collect serum and feces]
C, > D[Serum ELISA for anti-MAP antibodies]
C, > E[Fecal PCR for IS900]
D, >|Positive| F[Confirmatory fecal PCR or culture]
D, >|Negative| G
E, >|Positive| H[MAP infection confirmed. Classify shedding level]
E, >|Negative| I[Inconclusive. Consider repeat testing in 3-6 months]
F, > H
H, > J[Management action: cull or segregate]
G, > J
I, > K[Monitor herd-level prevalence]
K, > L[Annual herd screening with pooled PCR]
Serological Tests
Enzyme-linked immunosorbent assay (ELISA) for detection of anti-MAP antibodies in serum or milk is the most widely used herd-screening tool. Commercial ELISA kits generally utilize lipoarabinomannan (LAM) or protoplasmic antigen extracts from MAP. Sensitivity of serum ELISA is stage-dependent: it is poor (below 30%) in early subclinical infection but can exceed 85% in clinically affected animals. Specificity is high (above 98%) when appropriate absorption steps are included to remove cross-reacting antibodies against environmental mycobacteria. Milk ELISA offers moderate sensitivity for lactating cows and is advantageous for routine bulk-tank monitoring.
Comparative Serology and Cross-Reactivity
Antibodies to MAP show cross-reactivity with other members of the Mycobacterium avium complex and with Mycobacterium bovis, the causative agent of bovine tuberculosis. Serological cross-reactivity complicates interpretation in herds with concurrent tuberculosis infection. In such settings, the comparative intradermal tuberculin test and ancillary interferon-gamma assays are required to differentiate infections. This diagnostic challenge is similar to that faced with other intracellular bacteria where serology alone is insufficient for definitive diagnosis.
Necropsy and Histopathology
Postmortem diagnosis relies on identification of characteristic gross and histopathological lesions in the ileum, ileocecal valve, and associated lymph nodes. Ziehl-Neelsen staining of tissue impression smears or fixed sections reveals numerous acid-fast bacilli within macrophages. PCR on fresh or formalin-fixed paraffin-embedded tissue can confirm IS900 presence.
Treatment
There is no effective treatment for Johne's disease in cattle. Antimicrobial therapy with rifampin, streptomycin, or macrolides is not recommended due to poor intracellular penetration, the risk of generating antimicrobial resistance, and the zoonotic implications of MAP. Regulatory restrictions in most jurisdictions prohibit the use of antibiotics for animals with Johne's disease as a matter of food safety. Treatment is exclusively palliative, and affected animals should be culled to reduce herd-level transmission.
Control and Prevention
Control of Johne's disease is based on preventing transmission from infected adult cows to susceptible calves. A comprehensive herd management plan incorporates the following elements.
Calf Management
All control programs begin with calf management. Calves must be separated from adult cows immediately after birth. Colostrum should be sourced from known MAP-negative cows or from a pool of colostrum that has been heat-treated (60 degrees Celsius for 60 minutes) to inactivate MAP. Calves should be raised in clean, separate facilities where they have no contact with adult manure or slurry. This management principle is analogous to the separation strategies applied in other enteric infections of young livestock.
Testing and Culling
Herd-level testing programs identify and remove shedding animals. The standard approach is annual testing of all adult cows using serum or milk ELISA. Animals that test positive should be culled or immediately segregated to a separate group destined for slaughter. Repeat fecal PCR testing of ELISA-negative animals can identify low-level shedders that are seronegative. Pooled fecal PCR screening of young stock is a valuable adjunctive tool for detecting early infections before seroconversion.
Biosecurity
Introduction of replacement animals is a major risk factor for introducing MAP into a naive herd. All incoming stock should originate from Johne's disease-free herds or should be tested via fecal PCR prior to entry. Quarantine and repeated testing over a six-month interval are recommended. Contaminated equipment, shared trucks, and manure spreaders represent fomite risks.
Vaccination
An inactivated whole-cell vaccine for MAP is available in some countries. Vaccination reduces clinical disease incidence and fecal shedding but does not prevent infection. Vaccinated animals seroconvert, rendering serological surveillance ineffective. Vaccination cannot be used in herds where bovine tuberculosis is endemic due to interference with the tuberculin test. The decision to vaccinate must weigh the loss of diagnostic monitoring against the reduction in clinical cases.
Pasture and Manure Management
Contaminated pastures should be rested for at least 12 months before grazing with naive calves. Composting manure prior to field application can reduce MAP viability. In contrast to the rapid decomposition of many enteric bacteria, MAP's lipid-rich cell wall ensures prolonged survival, making contact with fresh manure the most important transmission route.
Zoonotic Considerations
While this article maintains a veterinary focus, it is noted that MAP has been controversially linked to Crohn's disease in humans via the hypothesis that MAP acts as a triggering pathogen in genetically susceptible individuals. Specific human clinical data are not discussed. The presence of viable MAP in commercial pasteurized milk has been reported in some studies, which has driven regulatory interest in reducing herd-level prevalence.
References
[1] Sweeney, R.W. (2012). Pathogenesis of Mycobacterium avium subsp. paratuberculosis infection in cattle. Veterinary Clinics of North America: Food Animal Practice.
[2] Nielsen, S.S. and Toft, N. (2008). Ante mortem diagnosis of paratuberculosis: a review of accuracies of ELISA, interferon-gamma assay and faecal culture techniques. Veterinary Microbiology.
[3] Collins, M.T. (2011). Diagnosis of paratuberculosis. Veterinary Clinics of North America: Food Animal Practice.
[4] McKenna, S.L.B., et al. (2005). Comparison of four methods for detection of Mycobacterium avium subsp. paratuberculosis in fecal samples. Journal of Veterinary Diagnostic Investigation.
[5] Whittington, R.J. and Sergeant, E.S.G. (2001). Progress towards understanding the spread, detection and control of Mycobacterium avium subsp. paratuberculosis in animal populations. Australian Veterinary Journal.
[6] Garvey, M. (2018). Mycobacterium avium subspecies paratuberculosis: the relationship to Crohn's disease and proposed diagnostic strategies. Veterinary Journal.